Podcast: Play in new window | Download | Embed

Subscribe: RSS | More

In Episode 28 of The Med Edit Podcast, co-hosts Dr. Jessica Gray and Dr. Cari Sorrell welcome Dr. Ann Bass, a Board Certified Obesity Medicine Specialist, to discuss some hot-button health topics, including obesity, weight loss medications, and the recent FDA ban on Red Dye #3.

We dive into:

• The current state of obesity treatment and why traditional methods might not work for everyone.
• The safety and effectiveness of GLP-1 medications like semaglutide and tirzepatide, and the risks associated with compounded versions.
• The FDA’s controversial decision to ban Red Dye #3 in foods and what this means for consumers.

If you’re interested in learning the truth behind some of today’s most talked-about health topics, tune in to this episode now!

Connect with Dr. Jessica Gray and Dr. Cari Sorrell: 

• The Med Edit Podcast
• Instagram: @TheMedEditPodcast
• Facebook: The Med Edit Podcast
• LinkedIn: The Med Edit Podcast
• LinkedIn: Dr. Jessica Gray
• LinkedIn: Dr. Cari Sorrell
• Youtube: The MedEdit Podcast
• TikTok: The MedEdit Podcast

 

⚕️Texas Tech University Health Sciences Center:

•  Continuing Medical Education Credit

In support of improving patient care, this activity has been planned and implemented by Texas Tech University Health Sciences Center and The Med Edit Podcast. Texas Tech University Health Science Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

References from today’s episode:

https://www.obesityaction.org/education-support/learn-about-obesity/common-myths/

https://pmc.ncbi.nlm.nih.gov/articles/PMC4229150/

https://www.cdc.gov/obesity/adult-obesity-facts/index.html

https://www.cdc.gov/obesity/childhood-obesity-facts/childhood-obesity-facts.html

https://www.abom.org/history/

Casanova N, Beaulieu K, Finlayson G, Hopkins M. Metabolic adaptations during negative energy balance and their potential impact on appetite and food intake. Proc Nutr Soc. 2019 Aug;78(3):279-289. doi: 10.1017/S0029665118002811. Epub 2019 Feb 19. PMID: 30777142.

https://www.thelancet.com/journals/landia/article/PIIS2213-8587(18)30288-2/fulltext

https://www.thelancet.com/action/showPdf?pii=S0140-6736%2816%2930175-1

https://pmc.ncbi.nlm.nih.gov/articles/PMC4562400/

https://pubmed.ncbi.nlm.nih.gov/37271576/

https://pmc.ncbi.nlm.nih.gov/articles/PMC3014770/

https://www.fda.gov/food/hfp-constituent-updates/fda-revoke-authorization-use-red-no-3-food-and-ingested-drugs

https://www.fda.gov/drugs/drug-safety-and-availability/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize

https://www.forbes.com/sites/maryroeloffs/2025/01/15/fda-bans-use-of-red-dye-no-3-in-foods-what-to-know-about-the-chemical/

https://www.reuters.com/business/healthcare-pharmaceuticals/fda-bans-red-dye-found-candy-cakes-2025-01-15/